{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-132132","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.427210+00:00","generated_at":"2026-05-28T23:01:00.670460+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ReShape Lifesciences enters up to $5M equity purchase agreement with investor","bullets":["Equity purchase agreement for up to $5M over 36 months; pricing at 93% of prior-day VWAP with a true-up mechanism.","Investor receives 17,300 shares and pre-funded warrant for 21,015 shares as commitment fee; short selling prohibited.","Issuance capped at 19.9% of outstanding shares unless stockholder approval or price exceeds Nasdaq Official Closing Price thresholds.","Proceeds expected for working capital and merger with Vyome Therapeutics; 66% of net proceeds must prepay existing convertible note.","Company filed S-1 to register resale of shares; agreement may be terminated by Company on 5 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-132132","json":"https://secwatch.observer/filing/0001104659-24-132132.json","markdown":"https://secwatch.observer/filing/0001104659-24-132132.md","text":"https://secwatch.observer/filing/0001104659-24-132132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924132132/0001104659-24-132132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924132132/tm2431533d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:01:00.670460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}